Newsroom
Sorted by: Latest
-
AngioInsight™ Announces First Patient Enrolled in SMARTFLOW™ Clinical Study
MINNETONKA, Minn.--(BUSINESS WIRE)--AngioInsight Inc.TM, a company advancing AI-powered cardiovascular diagnostics, today announced the enrollment of the first patient in the SMARTFLOWTM clinical study, marking a significant milestone in the clinical evaluation of AngioAI+TM, the company's investigational software platform designed to assess coronary physiology from routine coronary angiographic images. SMARTFLOW represents AngioInsight's first prospective, multicenter clinical study evaluating...
-
SoFi Expands Access to Private Markets with Funds From CAZ Investments and AngelList Asset Management
SAN FRANCISCO--(BUSINESS WIRE)--SoFi Technologies, Inc. (NASDAQ: SOFI), the everything app for digital financial services, today introduced three new private market funds from CAZ Investments and AngelList Asset Management. These funds provide exposure to private market strategies across AI, fintech, healthcare, defense, and other sectors, with investments that may include companies such as OpenAI, Anthropic, Anduril, and others. Investors are looking beyond traditional stocks and bonds, but th...
-
Brown-Forman First Quarter Earnings Release and Conference Call Scheduled for September 2, 2026
LOUISVILLE, Ky.--(BUSINESS WIRE)--Brown-Forman Corporation (NYSE: BFA, BFB) will release its first quarter of fiscal year 2027 financial results on September 2, 2026, by 8:00 a.m. (EDT), followed by a conference call to discuss the results at 10:00 a.m. (EDT). A live audio broadcast of the conference call will be available via Brown-Forman’s website, brown-forman.com, through a link to "Investors/Events & Presentations." A digital audio recording of the conference call will be available on...
-
Stoke Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. Today, the Company announced that Chief Executive Officer Ian F. Smith and Chief Patient Officer Jason Hoitt will present at the Canaccord Genuity 46th Ann...
-
Key Container Corporation Appoints Advisory Board to Support Next Phase of Growth
PAWTUCKET, R.I.--(BUSINESS WIRE)--Key Container Corporation ("Key Container"), a leading corrugated box manufacturer in New England, today announced the formation of its advisory board, bringing together four packaging industry experts to provide strategic guidance that will help the company better meet evolving customer needs while supporting its next phase of growth. The announcement builds on the company's continued momentum following Altamont Capital Partners' (“Altamont”) investment in Key...
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds Pursuant to their Managed Distribution Policy for the Months of September, October and November 2026
NEW YORK--(BUSINESS WIRE)--Source: Franklin Resources, Inc....
-
Toshiba Software Secures Global Stevie® Award
LAKE FOREST, Calif.--(BUSINESS WIRE)--Toshiba Software Secures Global Stevie® Award...
-
Expedition Therapeutics Announces Oversubscribed $115 Million Series B Financing to Advance Next-Generation DPP1 Inhibitor for COPD
SAN FRANCISCO--(BUSINESS WIRE)--Expedition Therapeutics Announces Oversubscribed $115 Million Series B Financing to Advance Next-Generation DPP1 Inhibitor for COPD...
-
Atlanta Braves Holdings Reports Second Quarter 2026 Financial Results
ATLANTA--(BUSINESS WIRE)--Atlanta Braves Holdings, Inc. (“ABH”) (Nasdaq: BATRA, BATRK) today reported results for its second quarter ended June 30, 2026. Highlights include: Total revenue of $305 million in the second quarter of 2026, down 2% from the prior year period. Total revenue of $377 million for the six months ended June 30, 2026, up 5% from the prior period. Baseball revenue decreased 4% from the prior year period to $276 million driven by six fewer home games played in the second quar...
-
‘Cheers to Beer’ Celebrates the Drink at the Heart of Life’s Meaningful Moments
LONDON--(BUSINESS WIRE)--Ahead of International Beer Day on August 7th, AB InBev, the world's leading brewer, launched “Cheers to Beer,” a new global campaign celebrating the timeless role beer plays in culture and communities around the world. The campaign is anchored by a new film, created in partnership with Wieden+Kennedy, that celebrates the many moments of cheers that beer creates across geographies and generations. The film, which will be amplified globally, reinforces beer's role in lif...